Fatty acid composition and plant extract and pharmaceutical preparation and application thereof

Fatty acid composition and plant extract and pharmaceutical preparation and application thereof

  • CN 103,796,651 A
  • Filed: 06/25/2012
  • Published: 05/14/2014
  • Est. Priority Date: 06/29/2011
  • Status: Active Grant
First Claim
Patent Images

1. Claim1st, a kind of aliphatic acid composition, it is characterised in that said composition contains linoleic acid, leukotrienes and oleic acid, it is preferable that the composition is made up of linoleic acid, leukotrienes and oleic acid.2nd, composition according to claim 1, wherein, on the basis of the weight of composition, the content of oleic acid is 0.5-99 weight % in the composition, and linoleic content is 0.5-99 weight %, and linolenic content is 0.5-99 weight0 /0

  • 3rd, a kind of aliphatic acid composition, it is characterised in that said composition contains linoleic acid, leukotrienes and oleic acid, and selected from least one of palmitic acid, palmitoleic acid, stearic acid, arachidic acid and behenic acid.4, composition according to claim 3, wherein, on the basis of the weight of composition, the content of oleic acid is 0.5-95 weight % in the composition, linoleic content is 0.5-95 weight %, linolenic content is 0.5-95 weight %, the content of palmitic acid is 0-8 weight %, the content of palmitoleic acid is 0-3 weight %, stearic content is 0-3 weight %, the content of arachidic acid is 0-1 weight %, the content of behenic acid is 0-1 weight %, and palmitic acid, palmitoleic acid, stearic acid, the total content of arachidic acid and behenic acid is 4-16 weight %.5th, the composition according to claim 3 or 4, wherein, said composition contains oleic acid, linoleic acid, leukotrienes, palmitic acid, palmitoleic acid, stearic acid, arachidic acid and the behenic acid for accounting for composition 95-100 weight %, preferably, the composition is made up of oleic acid, linoleic acid, leukotrienes, palmitic acid, palmitoleic acid, stearic acid, arachidic acid and behenic acid.6th, a Plant Extracts, it is characterised in that the plant extracts is that Suaeda plant S hides da) extract, preferably Suaeda salsa(

    Λ

    α

    β

    ^/^ (L.) Pall.) extract, alkali is fluffy(

    G/fl co Bge.) extract, silique alkali fluffy S.corniculata (C.A.Mey) Bunge) extract and the fluffy S.prostmta Pall. of prostration alkali) at least one of extract.7th, plant extracts according to claim 6, wherein, the Suaeda plant extract is the extract of Suaeda plant seed.8th, the plant extracts according to claim 6 or 7, wherein, on the basis of the weight of plant extracts, contain in the plant extracts:

    Content is 8-18 weight % oleic acid, content is 20-85 weight % linoleic acid, content is 1-35 weight % leukotrienes, content is 3-15 weight % palmitic acid, content is 0.5-5 weight % palmitoleic acid, content is 0.5-5 weight % stearic acid, and content is 0.1-3 weight % arachidic acid, and content is 0.01-0.5 weight% behenic acid;

    Preferably, contain in the plant extracts:

    Content is 8-18 weight % oleic acid, content is 60-82 weight % linoleic acid, content is 2-10 weight % leukotrienes, content is 6-12 weight % palmitic acid, content is 0.5-2 weight % palmitoleic acid, content is 0.5-3 weight % stearic acid, and content is 0.5-1 weight % arachidic acid, and content is 0.2-0.5 weight % behenic acid.9th, the plant extracts according to any one in claim 6-8, wherein, it is at least one of pressure Virgin methods, lixiviation process, supercritical extraction and water substitution to obtain the method for the plant extracts.10th, plant extracts according to claim 9, wherein, leachate used is the solvent that boiling point is 40-90 °

    C in the lixiviation process.11st, plant extracts according to claim 10, wherein, leachate used is at least one of No. 6 solvent naphthas, just own protective embankment, benzene, two chloroethene protective embankments, trichloro ethylene and gasoline in the lixiviation process.12nd, plant extracts according to claim 9, wherein, the extractant in the supercritical extraction is at least one of carbon dioxide, ethene, ammonia, nitrous oxide and dichlorodifluoro first protective embankment.13rd, a kind of pharmaceutical preparation, the pharmaceutical preparation contains active component, characterized in that, the active component includes at least one of plant extracts and the modified product of the plant extracts described in any one in the aliphatic acid composition and claim 6-12 described in any one in the aliphatic acid composition described in claim 1 or 2, claim 3-5.14th, pharmaceutical preparation according to claim 13, wherein, the active component is at least one of plant extracts and the modified product of the plant extracts described in any one in the aliphatic acid composition and claim 6-12 described in any one in the aliphatic acid composition described in claim 1 or 2, claim 3-5, and on the basis of the weight of pharmaceutical preparation, the content of active component is 1-100 weight % in the pharmaceutical preparation, and remaining is pharmaceutic adjuvant.15th, the pharmaceutical preparation according to claim 13 or 14, wherein, the formulation of the pharmaceutical preparation is at least one of paste, patch, suppository, hard capsule, soft capsule, aerosol, solution, emulsion, powder, tablet, pill, film and injection.16th, described in claim 1 or 2 application of at least one of the pharmaceutical preparation in the plant extracts and claim 13-15 in the aliphatic acid composition, claim 6-12 in aliphatic acid composition, claim 3-5 described in any one described in any one described in any one in the medicine for the treatment of exterior trauma and internal injury is prepared.17th, described in claim 1 or 2 application of at least one of the pharmaceutical preparation in the plant extracts and claim 13-15 in the aliphatic acid composition, claim 6-12 in aliphatic acid composition, claim 3-5 described in any one described in any one described in any one in the medicine for the neurotrosis for preparing treatment burn and scald or being caused by various wounds.18th, application according to claim 17, wherein, the burn and scald is the tissue damage caused by fire, electricity, radiation, ultraviolet, high-temp liquid, high-temperature gas, high-temp solid, chemical corrosivity material.19th, described in claim 1 or 2 at least one of pharmaceutical preparation in the plant extracts and claim 13-15 in the aliphatic acid composition, claim 6-12 in aliphatic acid composition, claim 3-5 described in any one described in any one described in any one prepare repair tissue fester or the medicine of necrosis in application.20th, application according to claim 19, wherein, the tissue fester or necrosis include that exanthemv or necrosis, muscle ulceration or necrosis, mucous membrane are festered or necrosis and cavity fester or at least one of necrosis.21st, described in claim 1 or 2 application of at least one of the pharmaceutical preparation in the plant extracts and claim 13-15 in the aliphatic acid composition, claim 6-12 in aliphatic acid composition, claim 3-5 described in any one described in any one described in any one in the medicine for preparing wound repair.22nd, application according to claim 21, wherein, the wound includes human body outer damage and internal injury.23rd, described in claim 1 or 2 application of at least one of the pharmaceutical preparation in the plant extracts and claim 13-15 in the aliphatic acid composition, claim 6-12 in aliphatic acid composition, claim 3-5 described in any one described in any one described in any one in cosmetics are prepared.24th, application according to claim 23, wherein, the skin care item include at least one of sun-screening agent, anti-chap preparation, skin moistening preparation, bathing preparation, cosmetic formulation and care formulations.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×